References
- Nordanstig J, Behrendt CA, Baumgartner I, Belch J, Bäck M, Fitridge R, et al. Editor's Choice -- European Society for Vascular Surgery (ESVS) 2024 Clinical Practice Guidelines on the Management of Asymptomatic Lower Limb Peripheral Arterial Disease and Intermittent Claudication. Eur J Vasc Endovasc Surg. 2024 Jan;67(1):9–96. doi: 10.1016/j.ejvs.2023.08.067
- Maillet A, Desormais I, Rivière AB, Aboyans V, Lacroix P, Mirault T, et al. Peripheral Atheromatous Arterial Disease in the Young: Risk Factors, Clinical Features, and Prognosis From the COPART Cohort. Angiology. 2017 Nov;68(10):893–8. doi: 10.1177/0003319717699501
- Campia U, Gerhard-Herman M, Piazza G, Goldhaber SZ. Peripheral Artery Disease: Past, Present, and Future. Am J Med. 2019 Oct;132(10):1133–41. doi: 10.1016/j.amjmed.2019.04.043
- Fontaine R, Kim M, Kieny R. [Surgical treatment of peripheral circulation disorders]. Helv Chir Acta. 1954 Dec;21(5–6):499–533.
- Russu E, Mureșan AV, Arbănași EM, Kaller R, Hosu I, Voidăzan S, et al. The Predictive Role of NLR and PLR in Outcome and Patency of Lower Limb Revascularization in Patients with Femoropopliteal Disease. Journal of Clinical Medicine. 2022 Jan;11(9):2620. doi: 10.3390/jcm11092620
- Mureșan AV, Florea E, Arbănași EM, Bartus R, Arbănași EM, Ion AP, et al. Elevated Leukocyte Glucose Index Is Associated with Long-Term Arteriovenous Fistula Failure in Dialysis Patients. Journal of Clinical Medicine. 2024 Jan;13(7):2037. doi: 10.3390/jcm13072037
- Danielsson P, Truedsson L, Eriksson KF, Norgren L. Inflammatory markers and IL-6 polymorphism in peripheral arterial disease with and without diabetes mellitus. Vasc Med. 2005 Aug;10(3):191–8. doi: 10.1191/1358863x05vm617oa
- Mureșan AV, Arbanasi EM, Bartus R, Mărginean L, Cordoș BA, Ciucanu CC, et al. Prognostic value of leukocyteglycemic index in long-term evolution of diabetic patients with peripheral arterial disease following endovascular treatment. Acta Marisiensis - Seria Medica [Internet]. 2024 May 29 [cited 2024 Nov 3];70(2). Available from:
https://ojs.actamedicamarisiensis.ro/index.php/amm/article/view/525 . doi: 10.2478/amma-2024-0013 - Sadeghi R, Roshdi Dizaji S, Vazirizadeh-Mahabadi M, Sarveazad A, Forouzannia SA. Prognostic Value of The Leuko-Glycemic Index in Acute Myocardial Infarction; a Systematic Review and Meta-Analysis. Arch Acad Emerg Med. 2023;11(1):e25. doi: 10.22037/aaem.v11i1.1915
- Mureșan AV, Tomac A, Opriș DR, Bandici BC, Coșarcă CM, Covalcic DC, et al. Inflammatory Markers Used as Predictors of Subclinical Atherosclerosis in Patients with Diabetic Polyneuropathy. Life (Basel). 2023 Sep 3;13(9):1861. doi: 10.3390/life13091861
- Sadeghi R, Haji Aghajani M, Parandin R, Taherpour N, Ahmadzadeh K, Sarveazad A. Leuko-Glycemic Index in the Prognosis of Acute Myocardial Infarction; a Cohort Study on Coronary Angiography and Angioplasty Registry. Arch Acad Emerg Med. 2023;11(1):e63. Published 2023 Sep 13. doi: 10.22037/aaem.v11i1.2085
- Peker T, Özbek M, Boyraz B, Aslan SF, Demir M, Aslan B. Prognostic value of the leuko-glycemic index in coronary chronic total occlusion patients. Eur Res J. 2023;9(5):1099–1104. doi: 10.18621/eurj.1342326
- Kaller R, Russu E, Arbănași EM, Mureșan AV, Jakab M, Ciucanu CC, et al. Intimal CD31-Positive Relative Surfaces Are Associated with Systemic Inflammatory Markers and Maturation of Arteriovenous Fistula in Dialysis Patients. Journal of Clinical Medicine. 2023 Jan;12(13):4419. doi: 10.3390/jcm12134419
- Kaller R, Arbănași EM, Mureșan AV, Voidăzan S, Arbănași EM, Horváth E, et al. The Predictive Value of Systemic Inflammatory Markers, the Prognostic Nutritional Index, and Measured Vessels' Diameters in Arteriovenous Fistula Maturation Failure. Life. 2022 Sep;12(9):1447. doi: 10.3390/life12091447
- Seoane LA, Burgos L, Espinoza JC, Furmento JF, Benzadón MN, Vrancic JM, et al. Prognostic Value of the Leuko-Glycaemic Index in the Postoperative Period of Coronary Artery Bypass Grafting. Braz J Cardiovasc Surg. 2021 Oct 15;36:484–91. doi: 10.21470/1678-9741-2020-0349
- Villalpando-Sánchez DC, Gómez-García A. Índice leucoglucémico como marcador de inflamación y disfunción endotelial en sobrepeso y obesidad [Leuko-glycemic index as a marker of inflammation and endothelial dysfunction in overweight and obesity]. Rev Med Inst Mex Seguro Soc. 2024;62(4):1–8. doi: 10.5281/zenodo.11397066
- de Marañón AM, Iannantuoni F, Abad-Jiménez Z, Canet F, Díaz-Pozo P, López-Domènech S, Roldán-Torres I, Morillas C, Rocha M, Víctor VM. Association between Proinflammatory Markers, Leukocyte–Endothelium Interactions, and Carotid Intima–Media Thickness in Type 2 Diabetes: Role of Glycemic Control. Journal of Clinical Medicine. 2020; 9(8):2522. doi: 10.3390/jcm9082522